IDentaIDTA 41 OCF Margin % is -5.87% as of Mar. 2026. GuruFocus rates IDTA with a GF Score™ of 41/100 and a GF Value™ of $0.32 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, IDenta ranks worse than 73.04% on this metric.
The historical rank and industry rank for IDenta's OCF Margin % or its related term are showing as below:
IDTA'
s OCF Margin % Range Over the Past 10 Years
Min: -12.53 Med: 5.29 Max: 37.97
Current: -24.35
During the past 8 years, the highest OCF Margin % of IDenta was 37.97%. The lowest was -12.53%. And the median was 5.29%.
IDTA's OCF Margin % is ranked worse than 73.04% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs IDTA: -24.35
IDenta OCF Margin % Related Terms
IDenta OCF Margin % Historical Data
* Premium members only.
The historical data trend for IDenta's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, IDenta's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDenta OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDenta's OCF Margin % distribution charts can be found below:
* The bar in red indicates where IDenta's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDenta (IDTA) has a OCF Margin % of -5.87% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on IDenta and its competitors. According to the industry distribution chart, IDenta ranks #149 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 73%.
Is IDenta's OCF Margin % too high?
IDenta's current OCF Margin % is -5.87%. Based on the distribution chart, IDenta ranks #149 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, IDenta has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IDenta's OCF Margin % compare to NSTM and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, IDenta ranks #149 out of 204 companies for OCF Margin %. This places IDenta in the lower half of its industry. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on IDenta and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDenta's current OCF Margin % is -5.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDenta stock overvalued right now?
Based on GuruFocus' analysis, IDenta (IDTA) is currently considered Possible Value Trap. The stock's GF Value™ is $0.32, compared to a current price of $0.22 — trading 31.3% below its estimated fair value. The current OCF Margin % is -5.87%. IDenta's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For IDenta (IDTA), the current OCF Margin % is -5.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDenta (IDTA) Overvalued in 2026?
Based on GuruFocus' analysis, IDenta stock appears to be undervalued.
The current stock price of $0.22 is trading 31.3% below its estimated GF Value™ of $0.32.
GuruFocus considers IDenta to be Possible Value Trap.
Key valuation signals for IDTA:
OCF Margin %: -5.87%
GF Value™: $0.32 vs. price of $0.22 (31.3% below fair value)
No single metric tells the full story. See the IDTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, ports and border crossings, shipping hubs, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Forensic products, Urine drug testing and others. The company currently sells its products to law enforcement organizations in the following countries: Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The company also sells to retail markets in the United States, Italy, and South Africa.
41GF Score
Get the complete analysis for IDTA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IDTA has been successfully added to your 
